Pricing pressure is not the root problem. It is exposing weaknesses in Pricing Governance, gross-to-net transparency, and commercial operating models. Discover why leading pharmaceutical organizations are responding through Commercial Transformation.

Aleksandar Ruzicic has been appointed Senior Vice President and Advisory Expert Member at Stratence Partners, strengthening pharma and healthcare transformation expertise.

Consultancy.uk featured Stratence Partners following EPA Amsterdam 2026, highlighting how healthcare organizations can transform pricing pressure, fragmented data, and Gross-to-Net complexity into structured, AI-Powered commercial decision systems.

🚀 EPA Congress 2025 was a resounding success! Packed sessions, high engagement, and great connections—thank you all! #StratencePartners

🚀 Fernando Ventureira leads the Pricing Track at EPA Congress 2025 today! Stop by Booth 50 to meet the team & discuss pricing strategy!

🚀 Fernando Ventureira kicks off EPA Congress 2025 today with key insights on Digital Transformation in Healthcare!

Fernando Ventureira leads key sessions at EPA Congress 2025 on Digital Transformation & Pricing Excellence.

Fernando Ventureira leads key sessions at EPA Congress 2025 on Digital Transformation & Pricing Excellence

Seasoned Global Healthcare Leader, Anh Bourcet (Nguyen) has a 15-year track record of driving excellence and transformation in Market Access

We are very glad to welcome Jérôme to the Stratence Partners’ Team as Vice President APAC, effective on July 1st, 2023 Jerome is an...